ONCO3 Stock Overview
Oncoclínicas do Brasil Serviços Médicos S.A. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Oncoclínicas do Brasil Serviços Médicos S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R$2.16 |
| 52 Week High | R$13.00 |
| 52 Week Low | R$1.93 |
| Beta | 0.88 |
| 1 Month Change | -40.98% |
| 3 Month Change | -60.29% |
| 1 Year Change | -81.82% |
| 3 Year Change | -81.76% |
| 5 Year Change | n/a |
| Change since IPO | -88.70% |
Recent News & Updates
Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Stocks Pounded By 29% But Not Lagging Market On Growth Or Pricing
Nov 23
Oncoclínicas do Brasil Serviços Médicos' (BVMF:ONCO3) Problems Go Beyond Weak Profit
Nov 20Oncoclínicas do Brasil Serviços Médicos S.A. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts
Nov 17Recent updates
Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Stocks Pounded By 29% But Not Lagging Market On Growth Or Pricing
Nov 23Oncoclínicas do Brasil Serviços Médicos' (BVMF:ONCO3) Problems Go Beyond Weak Profit
Nov 20Oncoclínicas do Brasil Serviços Médicos S.A. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts
Nov 17With A 25% Price Drop For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) You'll Still Get What You Pay For
Sep 27Here's What Analysts Are Forecasting For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) After Its Second-Quarter Results
Aug 15Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) Takes On Some Risk With Its Use Of Debt
Aug 13Earnings Tell The Story For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) As Its Stock Soars 27%
Jul 16Is Now An Opportune Moment To Examine Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)?
Jul 03Investors Appear Satisfied With Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Prospects As Shares Rocket 25%
Jun 01Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Share Price Is Still Matching Investor Opinion Despite 27% Slump
Apr 17Oncoclínicas do Brasil Serviços Médicos' (BVMF:ONCO3) Earnings Are Weaker Than They Seem
Apr 03Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) Has A Somewhat Strained Balance Sheet
Mar 11What Does Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Share Price Indicate?
Feb 17It's A Story Of Risk Vs Reward With Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)
Dec 08Why Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Could Be Worth Watching
Nov 06Is Now The Time To Put Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) On Your Watchlist?
Sep 11Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Just Reported Earnings, And Analysts Cut Their Target Price
Apr 03Shareholder Returns
| ONCO3 | BR Healthcare | BR Market | |
|---|---|---|---|
| 7D | -33.3% | -10.6% | -7.2% |
| 1Y | -81.8% | -31.7% | -11.5% |
Return vs Industry: ONCO3 underperformed the BR Healthcare industry which returned -30% over the past year.
Return vs Market: ONCO3 underperformed the BR Market which returned -9.2% over the past year.
Price Volatility
| ONCO3 volatility | |
|---|---|
| ONCO3 Average Weekly Movement | 13.5% |
| Healthcare Industry Average Movement | 6.9% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in BR Market | 9.2% |
| 10% least volatile stocks in BR Market | 2.7% |
Stable Share Price: ONCO3's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: ONCO3's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of BR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | n/a | Bruno Ferrari | www.grupooncoclinicas.com |
Oncoclínicas do Brasil Serviços Médicos S.A. provides healthcare services focused on oncology, hematology, and radiotherapy in Latin America. It offers diagnosis and treatment services, such as pathological analysis, cryotherapy, palliative care, delife, hilotherapy, molecular journey, laser therapy, integrative medicine, myelogram-bone marrow biopsy, OC care line, OC precision medicine, oncoACCESS, survivorship, telemedicine, genetic testing, personalized medicine and individualized treatment, and veinviewer. The company also provides services in the areas of chemotherapy, hormone therapy, molecular target drugs, immunotherapy, bone marrow transplant, catheter salinization and heparinization, and non-oncological infusions.
Oncoclínicas do Brasil Serviços Médicos S.A. Fundamentals Summary
| ONCO3 fundamental statistics | |
|---|---|
| Market cap | R$1.59b |
| Earnings (TTM) | R$72.39m |
| Revenue (TTM) | R$6.10b |
18.9x
P/E Ratio0.2x
P/S RatioIs ONCO3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ONCO3 income statement (TTM) | |
|---|---|
| Revenue | R$6.10b |
| Cost of Revenue | R$4.05b |
| Gross Profit | R$2.04b |
| Other Expenses | R$1.97b |
| Earnings | R$72.39m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Mar 27, 2025
| Earnings per share (EPS) | 0.11 |
| Gross Margin | 33.54% |
| Net Profit Margin | 1.19% |
| Debt/Equity Ratio | 127.0% |
How did ONCO3 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 08:59 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Oncoclínicas do Brasil Serviços Médicos S.A. is covered by 15 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Fred Mendes | BofA Global Research |
| Flavio Yoshida | BofA Global Research |
| Marcio Osako | Bradesco S.A. Corretora de Títulos e Valores Mobiliários |